Lataa...
The current state of the art for biological therapies and new small molecules in inflammatory bowel disease
The emergence of biologic therapies is arguably the greatest therapeutic advance in the care of inflammatory bowel disease (IBD) to date, allowing directed treatments targeted at highly specific molecules shown to play critical roles in disease pathogenesis, with advantages in potency and selectivit...
Tallennettuna:
| Julkaisussa: | Mucosal Immunol |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279599/ https://ncbi.nlm.nih.gov/pubmed/29907872 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41385-018-0050-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|